Status:
RECRUITING
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Dry Eye
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 270 patients...
Eligibility Criteria
Inclusion
- Age \>=18 and Age \<=65.
- Clinical diagnosis of dry eye disease with meibomian gland dysfunction.
Exclusion
- History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
- History of Otorhinolaryngology surgery.
- Pregnant or lactating women.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT06544447
Start Date
June 1 2021
End Date
October 1 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Beijing TongRen Hospital, Capital Medical University Beijing, China
Beijing, Beijing Municipality, China, 100730